This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (11)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Otolaryngology/ Head & Neck Surgery  • Endocrine Disease of Head & Neck  • Alert me on articles by topic

Ernest L. Mazzaferri, MD

JAMA. 2006;295:2179-2182.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The management of thyroid nodules poses several diagnostic dilemmas. The vast majority of thyroid nodules are asymptomatic and impalpable, such that only 4% to 7% of the adult US population has palpable thyroid nodules.¹ However, neck ultrasonography reveals a large reservoir of clinically silent impalpable nodules, termed incidentalomas, the prevalence of which (both benign and malignant) ranges from 30% to 60% in autopsy studies and from 19% to 67% in prospective clinical studies.² Thyroid nodules increase in prevalence with advancing age and are more prevalent in women. An ultrasound screening study of 96 278 German employees aged 18 to 65 years found that the presence of a thyroid nodule was 13% in women and 9% in men aged 26 to 35 years, increasing to almost 45% in women and 32% in men aged 55 years and older.³ Moreover, thyroid cancer, which is relatively rare, is found in . . . [Full Text of this Article]

Author Affiliation: Division of Endocrinology, University of Florida, Gainesville.

RELATED ARTICLE

Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
Louise Davies and H. Gilbert Welch
JAMA. 2006;295(18):2164-2167.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications
Xing
Endocr. Rev. 2007;28:742-762.
ABSTRACT | FULL TEXT  

Explaining the increasing incidence of differentiated thyroid cancer
How and Tabah
CMAJ 2007;177:1383-1384.
FULL TEXT  

Invited Commentary * Authors' Response
Langer et al.
RadioGraphics 2007;27:861-865.
FULL TEXT  

Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences
Duntas and Biondi
Eur J Endocrinol 2007;156:13-19.
ABSTRACT | FULL TEXT